Maze Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of MZE782 in Adults With PKU (NCT07694440) | Maze Therapeutics | 2026-06-23 |
| A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease (NCT06830629) | Maze Therapeutics | 2025-02-05 |
| A Randomized Phase 1 of of MZE001 in Healthy Volunteers (NCT05249621) | Maze Therapeutics | 2022-02-07 |
Track Maze Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.